SCHEMBL16129335

SCHEMBL16129335

C=CS(=O)(=O)NCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4095283 0.77 TGM2 (0.33)
SCHEMBL8033032 0.77 TGM2 (0.33)
SCHEMBL797931 0.72
SCHEMBL9067621 0.72
SCHEMBL2384816 0.72 CA1 (0.35)
SCHEMBL22042420 0.70
Hydrochloric Acid SCHEMBL18045366 0.70 CA12 (0.32)
SCHEMBL8840223 0.69
SCHEMBL8951789 0.69
SCHEMBL5365317 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161028-A1 SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE KURA ONCOLOGY, INC. (US) 2017-09-21 WO disclosed
WO-2014152588-A1 COVALENT INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2014-09-25 WO disclosed